Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia

被引:21
|
作者
Mpakou, Vassiliki E. [1 ,2 ]
Ioannidou, Heleni-Dikaia [1 ,2 ]
Konsta, Eugene [1 ,2 ]
Vikentiou, Myrofora [1 ,2 ]
Spathis, Aris [3 ]
Kontsioti, Frieda [1 ,2 ]
Kontos, Christos K. [4 ]
Velentzas, Athanassios D. [5 ]
Papageorgiou, Sotiris [1 ,2 ]
Vasilatou, Diamantina [1 ,2 ]
Gkontopoulos, Konstantinos [1 ,2 ]
Glezou, Irene [1 ,2 ]
Stavroulaki, Georgia [1 ,2 ]
Mpazani, Efthimia [1 ,2 ]
Kokkori, Stella [6 ]
Kyriakou, Elias [6 ]
Karakitsos, Petros [3 ]
Dimitriadis, George [1 ,2 ]
Pappa, Vasiliki [1 ,2 ]
机构
[1] Attikon Univ Hosp, Dept Internal Med 2, 1 Rimini St, Athens 12462, Greece
[2] Attikon Univ Hosp, Res Inst, 1 Rimini St, Athens 12462, Greece
[3] Attikon Univ Hosp, Dept Cytopathol, Athens, Greece
[4] Univ Athens, Dept Biochem & Mol Biol, Athens, Greece
[5] Univ Athens, Sch Sci, Sect Cell Biol & Biophys, Dept Biol, Athens, Greece
[6] Attikon Univ, Gen Hosp, Hematol Lab, Athens, Greece
关键词
Chronic lymphocytic leukemia (CLL); T regulatory cells; CLL cells; Apoptosis; Immunophenotype; SUPPRESSIVE FUNCTION; CD4(+); EXPRESSION; SUBPOPULATIONS; THERAPY; CTLA-4; CD127;
D O I
10.1016/j.leukres.2017.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulated data indicate a significant role of T cell dysfunction in the pathogenesis of chronic lymphocytic leukemia. In CLL, regulatory T cells are significantly higher and show lower apoptotic levels compared to healthy donors. We demonstrate that CLL derived CD4(+) CD25(-) CD127(-) and CD4(+) CD25(low)CD127(-) subpopulations share a common immunophenotypic profile with conventional Tregs and are associated with advanced stage disease. We further provide evidence that the increased number of Tregs contributes indirectly to the proliferation of the CLL clone, by suppressing the proliferation of Teffs which in turn suppress CLL cells. These data are further supported by our observations that CLL derived Tregs appear rather incapable of inducing apoptosis of both normal B cells and CLL cells, in contrast to normal Tregs, suggesting an immunoediting effect of CLL cells on Tregs which negatively affects the functionality of the latter and contributes to the failure of Tregs in CLL to efficiently eliminate the abnormal clone.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 50 条
  • [41] Merkel Cell Polyomavirus in Chronic Lymphocytic Leukemia T-Cells
    Cimino, P. J.
    Bahler, D. W.
    Duncavage, E. J.
    LABORATORY INVESTIGATION, 2012, 92 : 330A - 330A
  • [42] Differential adhesion pattern of B cell chronic lymphocytic leukemia cells
    SI Behr
    D Korinth
    F Schriever
    Leukemia, 1998, 12 : 71 - 77
  • [43] Differential adhesion pattern of B cell chronic lymphocytic leukemia cells
    Behr, SI
    Korinth, D
    Schriever, F
    LEUKEMIA, 1998, 12 (01) : 71 - 77
  • [44] RESIDUAL T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    GOLDSTONE, AH
    KERR, L
    URBANIAK, SJ
    FARMER, A
    IRVINE, WJ
    LANCET, 1973, 1 (7801): : 481 - 482
  • [45] T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    KAY, NE
    DOUGLAS, SD
    ESTREN, S
    LANCET, 1974, 2 (7892): : 1326 - 1326
  • [46] Early onset of T cell effector and regulatory dysfunction in precursors of chronic lymphocytic leukemia
    Rissiek, A.
    Bacher, U.
    Jacholkowski, A.
    Schulze, C.
    Schieferdecker, A.
    Horn, C.
    Haag, F.
    Tiegs, G.
    Trepel, M.
    Tolosa, E.
    Binder, M.
    ONKOLOGIE, 2013, 36 : 221 - 221
  • [47] Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression
    Mekinian, Arsene
    Quinquenel, Anne
    Belkacem, Koceila Ait
    Kanoun, Feriel
    Dondi, Elisabetta
    Franck, Emilie
    Boubaya, Marouane
    Mhibik, Maissa
    Baran-Marszak, Fanny
    Letestu, Remi
    Ajchenbaum-Cymbalista, Florence
    Levy, Vincent
    Varin-Blank, Nadine
    Le Roy, Christine
    CANCER GENE THERAPY, 2023, 30 (07) : 1018 - 1028
  • [48] Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression
    Arsène Mékinian
    Anne Quinquenel
    Koceïla Ait Belkacem
    Feriel Kanoun
    Elisabetta Dondi
    Emilie Franck
    Marouane Boubaya
    Maïssa Mhibik
    Fanny Baran-Marszak
    Rémi Letestu
    Florence Ajchenbaum-Cymbalista
    Vincent Lévy
    Nadine Varin-Blank
    Christine Le Roy
    Cancer Gene Therapy, 2023, 30 : 1018 - 1028
  • [49] Targeting chronic lymphocytic leukemia with B-cell activating factor receptor CAR T cells
    Qie, Yaqing
    Gadd, Martha E.
    Shao, Qing
    To, Tommy
    Liu, Andrew
    Li, Shuhua
    Rivera-Valentin, Rocio
    Yassine, Farah
    Murthy, Hemant S.
    Dronca, Roxana
    Kharfan-Dabaja, Mohamed A.
    Qin, Hong
    Luo, Yan
    MEDCOMM, 2024, 5 (09):
  • [50] High frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia (B-CLL) is decreased by thalidomide and fludarabine treatment.
    Giannopoulos, Krzysztof
    Schmitt, Michael
    Wlasiuk, Paulina
    Kowal, Malgorzata
    Podhorecka, Monika
    Rolinski, Jacek
    Dmoszynska, Anna
    BLOOD, 2006, 108 (11) : 598A - 598A